Position in CORT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,447,485
+$9,898,783 QoQ
Shares Held
212,162
+0.0% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 92%
None 8%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Derivatives in CORT
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$824,760
PutShares
23,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. CORT ranks #39 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in CORT
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,447,485 | 212,162 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,548,702 | 212,074 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $824,760 | 23,700 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $14,308,715 | 411,170 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,481,668 | 222,376 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $9,690,626 | 116,600 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $30,768,029 | 419,183 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,220,441 | 264,581 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $15,989,653 | 317,318 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,154,393 | 392,273 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,472,900 | 353,121 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,378,150 | 292,900 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,926,802 | 274,840 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,074,201 | 296,301 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,173,644 | 322,411 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,857,770 | 362,778 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $7,589,603 | 373,688 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,917,474 | 386,797 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,448,411 | 397,326 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,028,267 | 400,900 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,968,668 | 402,458 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,651,307 | 439,599 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,121,584 | 460,072 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,194,503 | 470,555 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,666,575 | 445,970 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,036,699 | 461,614 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,123,823 | 482,986 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,958,542 | 501,139 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||